...
首页> 外文期刊>American journal of rhinology >Medical management and diagnosis of chronic rhinosinusitis: A survey of treatment patterns by United States otolaryngologists.
【24h】

Medical management and diagnosis of chronic rhinosinusitis: A survey of treatment patterns by United States otolaryngologists.

机译:慢性鼻鼻窦炎的医疗管理和诊断:美国耳鼻喉科医生对治疗方式的调查。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

BACKGROUND: This study was performed to identify current patterns of diagnostic criteria and medical treatment for chronic rhinosinusitis (CRS) by otolaryngologists in the United States. METHODS: A 15-item survey was mailed to a random sample of 200 members of the American Academy of Otolaryngology-Head and Neck Surgery; statistical analysis was performed. RESULTS: The overall response rate was 40.0%. Of respondents, 73% defined CRS as lasting >12 weeks. Seventy-three percent also believed radiological imaging was necessary for definitive diagnosis, but only 30% believed nasal endoscopy was necessary. Regarding treatment, respondents reported use of oral antibiotics (94%) and nasal corticosteroids (94%) as part of maximum medical management; oral decongestants, oral mucoevacuants, and allergy testing were used only by about one-half of the respondents, and less frequently topical decongestants (38%), oral corticosteroids (36%), and oral antihistamines (27%) were used. Oral corticosteroids were more likely to be used by specialists that self-classified as rhinologists than by other otolaryngologists (p = 0.005), but rhinologists were less likely to use radiological imaging (p = 0.04) as a diagnostic criterion. Pediatric otolaryngologists used allergy testing in medical management more frequently than other otolaryngologists (p < 0.001). Overall, the basis for choice of maximal medical management was personal clinical experience (74%), rather than clinical research results or expert recommendations. CONCLUSION: We had a fairly small sample of returned surveys; therefore, our findings may not be generalizable to the entire population of U.S. otolaryngologists. Nevertheless, in our survey, U.S. otolaryngologists agree on the use of oral antibiotics and nasal corticosteroids as part of maximal medical management for CRS but do not agree on other adjuvant therapies or on the use of endoscopy as a diagnostic criterion.
机译:背景:这项研究的目的是确定美国耳鼻喉科医生目前对慢性鼻-鼻窦炎(CRS)的诊断标准和药物治疗的模式。方法:将一项15项调查问卷邮寄给200名美国耳鼻咽喉头颈外科学会成员的随机样本;进行统计分析。结果:总有效率40.0%。在受访者中,有73%将CRS定义为持续12周以上。 73%的人还认为放射成像对于明确的诊断是必要的,但只有30%的人认为鼻内窥镜检查是必要的。关于治疗,被调查者报告了口服抗生素(94%)和鼻皮质类固醇(94%)作为最大医疗管理的一部分;仅约一半的受访者使用了口服减充血剂,口服粘液排出剂和过敏反应测试,而使用局部减充血剂(38%),口服皮质类固醇(36%)和口服抗组胺药(27%)的频率较低。自定义为鼻科医师的专家比其他耳鼻喉科医师更倾向于使用口服皮质类固醇(p = 0.005),但鼻科医师不太可能使用放射成像(p = 0.04)作为诊断标准。小儿耳鼻喉科医师比其他耳鼻喉科医师更频繁地在医疗管理中使用过敏测试(p <0.001)。总体而言,选择最佳药物治疗的基础是个人临床经验(74%),而不是临床研究结果或专家推荐。结论:我们有相当少量的退回调查样本。因此,我们的发现可能无法推广到整个美国耳鼻喉科医生。不过,在我们的调查中,美国耳鼻喉科医生同意使用口服抗生素和鼻皮质类固醇激素作为CRS的最大药物治疗方法,但不同意其他辅助疗法或使用内镜作为诊断标准。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号